Skip to main content Skip to main menu
UF Health University of Florida
Clinical Child and Pediatric Psychology Department of Clinical and Health Psychology - College of public health and health professions
Apply to Our Program
Research Overview

Diabetes Technology

  1. Schmidt, M., Lu, J., Luo, W., Cheng L., Lee, M., Huang, R., Weng, Y., Kichler, J.C., Corathers, S.D., Jacobsen, L.M., Albanese-O’Neill, A., Smith, L., Westen, S., Gutierrez-Colina, A.M., Heckaman, L., Wetter, S.E., Driscoll, K.A., Modi, A. (2022). Learning experience design of an mHealth self-management intervention for adolescents with type 1 diabetes. Educational Technology Research and Development, 70, 2171-2209.
  2. Forlenza, G.P., Vigers, T., Berget, C. Messer, L., Lai, R.A., Basina, M., Maahs, D.M., Hood, K., Buckingham, B.A., Wilson, D.M., Wadwa, R.P., Driscoll, K.A., Pyle, L. (2022). Predicting success with a first-generation hybrid closed loop artificial pancreas system among children, adolescents, and young adults with type 1 diabetes: A model development and validation study. Diabetes Technology & Therapeutics, 24, 157-166.
  3. Messer, L.H., Cook, P.F., Lowe, N.K., Hood, K.K., Driscoll, K.A., Hernandez, T.L. (2022). Predicting optimal use of continuous glucose monitors in adolescents with type 1 diabetes: It’s about burden and benefit. Journal of Pediatric Nursing, 62, 23-29.
  4. Messer, L.H., Berget, C., Pyle, L., Vigers, T., Cobry, E., Driscoll, K.A., Forlenza, G.P. (2021). Real-world use of a new hybrid closed-loop improves glycemic control in youth with type 1 diabetes. Diabetes Technology & Therapeutics, 23, 837-843.
  5. Berget, C., Akturk, H.K., Messer, L.H., Vigers, T., Pyle, L., Snell-Bergeon, J., Driscoll, K.A., Forlenza, G.P. (2021). Real world performance of hybrid closed loop in youth, young adults, adults and older adults with type 1 diabetes: Identifying a clinical target for HCL use. Diabetes, Obesity, and Metabolism, 23, 2048-2057.
  6. Messer, L.H., Tanenbaum, M.L., Cook, P.F., Wong, J.J., Hanes, S.J., Driscoll, K.A., Hood, K.K. (2020). Cost, hassle, and on-body experience: Barriers to diabetes device use in adolescents and potential intervention targets. Diabetes Technologies and Therapeutics, 10, 760-767.
  7. Berget, C., Messer, L.H., Vigers, T., Frohnert, B., Pyle, L., Wadwa, R.P., Driscoll, K.A., Forlenza, G. P. (2020). Six months of hybrid closed loop in the real-world: An evaluation of children and young adults using the 670G system. Pediatric Diabetes, 21, 310-318.
  8. Messer, L.H., Berget, C., Vigers, T., Pyle, L., Geno, C., Wadwa, R.P., Driscoll, K.A., Forlenza, G. P. (2020). Real world hybrid closed-loop discontinuation: Predictors and perceptions of youth discontinuing the 670G system in the first 6 months. Pediatric Diabetes, 21, 319-327.
  9. Messer, L H., Cook, P., Tanenbaum, M.L., Hanes, S., Driscoll, K.A., Hood, K.K. (2019). CGM Benefits and Burdens: Two brief measures of continuous glucose monitoring. Journal of Diabetes Science & Technology, 13, 1135-114.
  10. Berget, C., Driscoll, K.A., Lagges, A., Lange, S., DiMeglio, L.A., Hannon, T.S., Woerner, S.E., Iturralde, E., Barley, R.C., Hanes, S., Hood, K.K., Buckingham, B.B. (2019). Optimizing the use of continuous glucose monitoring in young children with type 1 diabetes with an adaptive study design and multiple randomizations. Contemporary Clinical Trials, 82, 60-65.
  11. Forlenza, G.P., Messer, L.H., Berget, C., Wadwa, R.P., Driscoll, K.A. (2018). Biopsychosocial factors associated with satisfaction and sustained use of artificial pancreas technology and its components: A call to the technology field. Current Diabetes Reports. 18, 114.
  12. Messer, L.H., Johnson, R., Driscoll, K.A., Jones, J. (2018). Best friend or spy: A qualitative meta-synthesis on the impact of continuous glucose monitoring on life with type 1 diabetes. Diabetic Medicine, 35, 409-418.
  13. Driscoll, K.A., Young-Hyman, D. (2014). Use of technology when assessing adherence to diabetes self-management behaviors. Current Diabetes Reports, 14, 521.